Markets seem happy for now to focus on the carrot of a vaccine while ignoring the stick of the further severe restrictions to life and liberty being implemented while we await its delivery. Whether or not it offers a release from bondage, the state’s rediscovered taste for authoritarianism will, however, take some good time to dispel, while its corollary – the move toward taking an ever greater role amid the wreckage of the private economy – is being pursued with relish. Whatever the sloganizing, this is very unlikely to Build anything Back Better – only dearer and scarcer.
We ended the summer by saying that – barring another disastrous, COVID19-inspired, mass governmental embargo on everyday economic activity – the miners, makers, movers, and merchants of the things we need to run our lives when we are not scrolling through Instagram or pretending to pay attention to a yet another pointless Zoom conference would begin to make up ground lost in lockdown to the providers of such diversions. State interference would henceforth take other, more chronic forms of hindrance: tending deliberately to boost demand while making its satisfaction progressively more difficult. So far – broadly speaking – so good.
The ink has not even dried on the US ballot papers (!) but the Market already thinks it knows what this will all mean. And then there’s Pfizer’s vaccine announcement – perhaps similarly preliminary in nature – but, hey, the Herd will always take every silver lining it can find. Some of the themes we touched upon at the end of the Summer are still in play: Japan has been attracting money, non-oil commodities are rallying, gold has lost some lustre, bond yields are creeping higher, and Value may just be topping out at last v Growth.
On the eve of what is shaping up to be a particularly momentous US election, we offer our view of what is at stake – both in the markets and out in the real world, far beyond the flickering screens of the trading room.
This essay attempts a review of the economics – and the prevailing economic thinking – which have brought us to our present pass of high-leverage and heavy debt-dependence. It helps set the backdrop for an in-depth look at markets which will follow shortly…
While stocks have generally tended to offer better returns than Treasuries, it has not all been plain sailing for equity investors. Intriguingly, the last 50 years’ ups and downs share more than a few similarities with the first half of the last century. Could that uncanny resemblance continue to hold henceforward?
Bond yields have started to creep higher – and curves to flex steeper – as the market begins to fret that the willing fiscal subservience of the central bank can only presage a coming inflation. With bond volatility still reasonably cheap, now might be the time to take cognisance of this.
The Johnson government’s approach to COVID19 has been a toxic mix of contradiction, vacillation, and jackbooted authoritarianism. There seems no exit strategy and no end to the spiralling cost. We take a critical look at the impact on the budget impact and discuss what it means for inflation.
Though the latest set of profit data for China’s industrial concerns were outwardly positive, there are still many unresolved questions hanging over both the economy and the country’s politics, some of which we examine here. None of that is likely to deter bond investors and ETF buyers, of course, since their principal concern will be to bring their holdings into line with a major benchmark index which has just created a vast source of funds for Xi Jinping’s minions to exploit. We ask: should they?
If we compare like with like, we find that the semi-mythical ‘equity risk premium’ may not be quite the yardstick it’s made out to be. In fact, the right sort of bonds have proven every bit as rewarding as stock, over the years and it’s cheap to bet they might do so again